Tempest Therapeutics, Inc. (TPST)
1.84
-0.08
(-4.17%)
USD |
NASDAQ |
May 13, 16:00
1.86
+0.02
(+1.09%)
After-Hours: 06:39
Tempest Therapeutics Shareholders Equity (Quarterly) : 6.668M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -221.22M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.13M |
| Total Liabilities (Quarterly) | 12.46M |
| Debt to Equity Ratio | 1.221 |
| Current Ratio | 2.495 |
| Net Debt Paydown Yield | 13.57% |